Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00237991 |
GlaxoSmithKline Korea has submitted a registration file for its hepatitis A vaccine. The present study will collect clinical data in the local target population as per the requirement of Korean Food and Drugs administration (FDA).
Condition | Intervention |
---|---|
Hepatitis A |
Biological: Hepatitis A |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | A Multicentric, Post-Marketing Surveillance to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals Hepatitis A Vaccine Administered in Korean Population. |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion criteria
Exclusion criteria
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | 104147 |
Study First Received: | October 12, 2005 |
Last Updated: | October 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00237991 |
Health Authority: | Korea: Food and Drug Administration |
Virus Diseases Hepatitis Liver Diseases Digestive System Diseases |
Picornaviridae Infections Hepatitis, Viral, Human Hepatitis A Enterovirus Infections |
RNA Virus Infections |